Feeds
Eli Lilly & Co. said Friday its science and technology head will retire. The drugmaker hired the chief researcher at AstraZeneca PLC to replace him.
Utah has agreed to a $24 million settlement with Eli Lilly & Co. over claims the drugmaker engaged in off-label marketing of the anti-psychotic drug Zyprexa, Utah Attorney General Mark Shurtleff said Wednesday.
South Carolina's attorney general said Friday the state has reached a $45 million settlement with drug maker Eli Lilly & Co. over the company's marketing of an anti-psychotic drug, an agreement the drug maker said was its largest with a single state over Zyprexa.
There are some life experiences few will ever have. And as the oldest of nine children and CEO of a Fortune 500 company, John Lechleiter has a couple under his belt.
GE Healthcare said Wednesday it plans to expand a cancer drug research partnership with Eli Lilly & Co., making a two-year-old partnership official in the process.
Eli Lilly & Co. turned a third-quarter profit as sales volume on several drugs climbed, but its newest drug and a possible key source of future revenue started slowly.
Connecticut officials say Eli Lilly & Co. has agreed to a $25 million settlement with the state over claims the drugmaker marketed its anti-psychotic drug Zyprexa for unapproved uses and harmed patients.
Biotechnology company Adolor Corp. said Monday it bought exclusive worldwide rights to Eli Lilly & Co.'s OpRA III drug candidate, which has a range of potential uses.
Seeking to cut costs and bring new drugs to market more quickly as its best-sellers go off-patent, drugmaker Eli Lilly & Co. said Monday it will eliminate 5,500 jobs over two years and reorganize into five business units.
Biotechnology company Dyax Corp. said Wednesday it received a $1.5 million payment as Eli Lilly & Co. moved a potential leukemia treatment into early-stage clinical trials.
In an Aug. 18 story about Eli Lilly and Co.'s osteoporosis drug, The Associated Press reported erroneously that the drug failed to meet key study goals. Instead, the drug met the goals, but the company is not seeking Food and Drug Administration approval.
Eli Lilly & Co. said Tuesday it will not seek Food and Drug Administration approval for its developing postmenopausal osteoporosis drug because of certain study results and safety concerns.
A federal court ruling that invalidated a patent protecting Eli Lilly and Co.'s cancer drug Gemzar surprised at least one analyst covering the company but stirred little reaction from investors in trading Tuesday.
Shares of Eli Lilly & Co. fell Monday after a Goldman Sachs analyst cut his rating on the drug developer to "Sell," citing the outlook for dwindling revenue and more spending to rebuild the product pipeline.
Eli Lilly & Co. said Tuesday it is offering buyouts to 4,000 U.S. sales representatives with the hope of eliminating a few hundred jobs.
Eli Lilly and Co.'s second-quarter profit rose 21 percent but the drugmaker's share price lagged Wednesday, as investors wait to learn more about how the company will handle a daunting revenue hole that looms a few years away.
The Food and Drug Administration on Friday approved a highly anticipated blood thinner from Eli Lilly, though the drug must carry the agency's sternest warning because of its bleeding risks.
Consumer health advocates and a co-developer of a highly anticipated blood thinner from Eli Lilly are calling on the Food and Drug Administration to halt its review of the drug, which they say may be unsafe at the suggested dose.
Amylin Pharmaceuticals Inc. said Monday activist investor Carl Icahn plans to push for a sale of the company to drugmaker Eli Lilly if he can take control of Amylin's board of directors, but Icahn disputed that contention.
Drugmaker Eli Lilly and Co. saw its first-quarter profit soar on strong sales but then watched its stock price dip Monday on a rough day for the broader market.
An influential cardiologist who criticized an experimental Eli Lilly drug should not have been barred from a panel that evaluated the drug's safety, federal health officials said.
Pfizer and Eli Lilly are promoting drugs to treat fibromyalgia, an ailment characterized by pain, fatigue and depression. But some doctors say the marketing buzz is drowning out important questions about the condition, including:
Former Eli Lilly & Co. Chairman and Chief Executive Sidney Taurel saw his total pay flatten out during his last year on the job, but retirement nest eggs totaling more than $40 million are waiting for him, according to regulatory filings.
Federal health regulators are looking into evidence that an Eli Lilly drug used to treat blood poisoning worsens the risk of bleeding and can lead to death in certain patients.
A panel of government health experts said Tuesday a highly anticipated Eli Lilly blood thinner marks a significant advance over older treatments and should be approved.
Gary Null: I'd like to welcome all of you, especially the Voice of America people all over the world, over a hundred and sixty countries.
Eli Lilly paid 39 Central Florida doctors a total of $231,825 in speaking fees to discuss its drugs Florida Hospital Celebration Health endocrinologist Damon Tanton was paid $12,637.50 to talk to doctors about the diabetes drug Byetta for manufacturer Eli Lilly and Co.
CVS / Lilly in sweetheart deal marketing Zyprexa to insurersA CVS subsidiary offered to send 120,000 letters to doctors promoting Zyprexa - at a charge of $5 per letter. A unit of CVS Caremark Corp.
Study: Viagra & Cialis Do Not Harm VisionReuters reports that a study funded by Pfizer and Eli Lilly & Company has found that men who took Viagra or Cialis daily for six months did not develop any significant vision problems.
A Grim Truth About Big PharmaLast month the New York Times exposed yet another example of unethical marketing practices by pharmaceutical giant Eli Lilly.
How to Stop Depression Medications: Very SlowlyNow that the Food and Drug Administration has warned Americans taking antidepressants to be on the lookout for potentially harmful side effects, including severe restlessness and suicidal thinking, some people may end up stopping the drugs.
Eli Lilly Settles Zyprexa Case With States for $62 MillionEli Lilly has agreed to pay $62 million to 33 states to settle claims that it improperly marketed Zyprexa, its top-selling drug, to patients who did not have schizophrenia or bipolar disorder, its only approved uses.
Former FDA Official Testifies that Eli Lilly Lied about Drug Side EffectsThe state of Alaska is suing Eli Lilly to recover the money that the state Medicaid system paid out to treat the serious health problems caused by Zyprexa. John Gueriguian, who was an FDA employee for 20 years, was hired by the prosecution to analyze internal Eli Lilly documents.
FDA Notes 2 Byetta DeathsThe FDA today said it plans to strengthen warnings about life-threatening pancreas problems linked to the type 2 diabetes drug Byetta after getting two reports of deaths and four other hospitalizations in Byetta users. Those patients had hemorrhagic pancreatitis (inflammation of …
Who produced LSD for the CIA and MK-ULTRA in 1954?In 1953 the CIA provided Eli Lilly with funding to attempt synthesis of LSD for CIA use without the need for the expensive and scarce reagents required by Sandoz. A year later, Lilly chemists succeeded in their quest, and subsequent supplies were from Lilly
Daily Sex Pill by Eli Lilly Promises to Bring Back Spontaneous SexThe drug differs from standard Cialis and Viagra tablets, which are taken before a planned sexual interlude.
Lechleiter takes Lilly Top JobLechleiter inherits the biggest problem facing Big Pharma today: beefing up the pipeline in the face of disappearing blockbusters.
Daring to Think Differently About SchizophreniaSCIENTISTS who develop drugs are familiar with disappointment — brilliant theories that don't pan out or promising compounds derailed by unexpected side effects.
ELFCU creates fun program to teach young customers how to spend less, save moreTo kids, Seymour de Green is a cute little frog who spends his time buying toys, snacking on horsefly tarts and emptying his piggy bank for pizza and movies.
Lilly gets U.S. approval for Prozac for poochesMan's best friend may have a new best friend after Eli Lilly and Co. won U.S. approval to sell its former blockbuster antidepressant Prozac to treat misbehaving mutts.
Study shows Drug Reps Sway Doctors' Choices As much as doctors would like to deny it, subtle attention from friendly drug sales representatives can have a big impact on what drugs they prescribe, according to two U.S. studies published on Monday.
Say it aint so....Lilly back in the court defending allegations of bribing in order for Zyprexa to be used off indication.
Pen injector keeps track of patients' insulin shotsBattelle scientists have designed an insulin injector that looks like a fountain pen and remembers how much of the drug you've taken and when. The injector, which hides a hypodermic needle, was unveiled today at Battelle.
Seattle Times: 2006 Business & Technology ReviewTop 2006 ten news stories from the Seattle Times, for the Seattle tech and business sectors. Some of the highlights include:
Crime Report - Drug Files Show Eli Lilly Promoted Unapproved UseBusiness as usual for the drug dealers, who incidently gave up the practice of hiring geeky science savvy sales in favor of PAC 10 cheerleaders a few years ago. Rah, rah, go team, medicate everyone for something.
Drug Company Suppressed $4.2 Billion Schizophrenia Drug's DangersTEL AVIV (MarketWatch) - Eli Lilly & Co.
A call for consumer privacy legislationTwelve major U.S. companies sign a call for the creation of a federal consumer privacy standard. "A baseline U.S. federal consumer privacy law will help protect all of us online," says Nicole Wong, Google Associate General Counsel.
Prescription For an Obsession?When Wayne Kanuch received a diagnosis of Parkinson's disease in 1993, the last thing he imagined was that the drug prescribed to treat his illness would turn him into a compulsive gambler and put his libido into overdrive.
Log In | Register
